Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Meza-Romero

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Dual surface selection methodology for the identification of thrombin binding epitopes from hotspot biased phage-display librariesSrivats Rajagopal, Roberto Meza-Romero, Indraneel Ghosh
Cellular Immunology|June 22, 2020
Surviving the storm: Dealing with COVID-19Arthur A Vandenbark, Roberto Meza-Romero, Halina Offner
Metabolic Brain Disease|December 16, 2014
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosisGil Benedek, Roberto Meza-Romero, Dennis Bourdette, et al.
Journal of Neuroinflammation|January 27, 2019
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injuryArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Metabolic Brain Disease|December 1, 2022
PD-L1 is required for estrogen-induced protection against severe EAE in IL-10 deficient mice<sup>1</sup>Halina Offner, Denesa Lockwood, Roberto Meza-Romero, et al.
Metabolic Brain Disease|February 8, 2016
Predicted structure of MIF/CD74 and RTL1000/CD74 complexesRoberto Meza-Romero, Gil Benedek, Lin Leng, et al.
Journal of Neuroinflammation|June 25, 2015
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotectionGil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.
Investigative Ophthalmology & Visual Science|December 15, 2011
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 miceGrazyna Adamus, Lori Brown, Shayne Andrew, et al.
Metabolic Brain Disease|October 25, 2018
Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular constructRoberto Meza-Romero, Gil Benedek, Grant Gerstner, et al.
The Journal of Biological Chemistry|May 30, 2003
Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptideRachel H McMahan, Lisa Watson, Roberto Meza-Romero, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Dual surface selection methodology for the identification of thrombin binding epitopes from hotspot biased phage-display librariesSrivats Rajagopal, Roberto Meza-Romero, Indraneel Ghosh
Cellular Immunology|June 22, 2020
Surviving the storm: Dealing with COVID-19Arthur A Vandenbark, Roberto Meza-Romero, Halina Offner
Metabolic Brain Disease|December 16, 2014
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosisGil Benedek, Roberto Meza-Romero, Dennis Bourdette, et al.
Journal of Neuroinflammation|January 27, 2019
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injuryArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Metabolic Brain Disease|December 1, 2022
PD-L1 is required for estrogen-induced protection against severe EAE in IL-10 deficient mice<sup>1</sup>Halina Offner, Denesa Lockwood, Roberto Meza-Romero, et al.
Metabolic Brain Disease|February 8, 2016
Predicted structure of MIF/CD74 and RTL1000/CD74 complexesRoberto Meza-Romero, Gil Benedek, Lin Leng, et al.
Journal of Neuroinflammation|June 25, 2015
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotectionGil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.
Investigative Ophthalmology & Visual Science|December 15, 2011
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 miceGrazyna Adamus, Lori Brown, Shayne Andrew, et al.
Metabolic Brain Disease|October 25, 2018
Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular constructRoberto Meza-Romero, Gil Benedek, Grant Gerstner, et al.
The Journal of Biological Chemistry|May 30, 2003
Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptideRachel H McMahan, Lisa Watson, Roberto Meza-Romero, et al.
Pageof 4